RE:RE:RE:RE:RE:RE:Calgary heraldThe Market is being extremely inefficient, I cant argue that at all. Just as it was when the governement funding for phase II was announced. The biosciences Sector is extremely difficult to understand and for most they get emotional in times what should be jovial.
The data from Phase II is currently waiting on the publication, which will derisk further for those who want to enter with funds etc. Statistically speaking Metablok/Lsalt Peptide increased the probability of success in regulatory approval yesturday from 15-53%. The clear signal in the Data that was released now brings credability to the entire Dipep-1 library of 8 drugs.
Fully Patented and a decade ahead of any pears in the human trial process, I have never felt better as a long term shareholder. The Facts are laid out in the news release, If you dont think the market beleives the facts becuase they are too good, that is when I typically buy more shares.
Great Discussion guys, I am very pleased with proceeding into a Phase III trial that is conducted by CATCO and Fully Funded by the Governement. It pleases me Greatly that the Company has the drug on hand to perform this trial and with Health Canada approval the timeline to potentially substantial shareholder growth is alot closer.